A SPAC I Acquisition Corp.
Status: Closed Deal
U=S+(3/4)W+R
W=S@11.50
R=S/10
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Feb 15, 2022 |
| CEO | Claudius Tsang |
| Left Lead | Chardan |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 8 + 6 |
| IPO Sector | Technology ▶ |
| IPO Geography | Global |
| Target Company | NewGenIvf |
| Deal Announced | Feb 16, 2023 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Mar 4, 2024 |
| Amendment Vote | Oct 9, 2023 |
| Closing Date | Apr 3, 2024 |
Formerly ASCA
NIVF
NIVFW
| Price | $1.47 $0.00 |
|---|---|
| Last closing price | $2.06 |
| H/L, today | $1.30 / $1.60 |
| Volume, today | 8,969,968 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.